Region einschränken

  • ganze Stadt
  • 5 km
  • 10 km
  • 30 km
  • 50 km
  • 100 km
  • 200 km
Im Umkreis von
  • alle Bundesländer
  • Baden Württemberg
  • Bayern
  • Berlin
  • Brandenburg
  • Bremen
  • Hamburg
  • Hessen
  • Niedersachsen
  • Nordrhein Westfalen
  • Mecklenburg Vorpommern
  • Saarland
  • Rheinland-Pfalz
  • Sachsen
  • Sachsen Anhalt
  • Schleswig Holstein
  • Thüringen
Die Fortbildungsangebote sind momentan wegen der Corona-Pandemie nicht oder nur eingeschränkt verfügbar. Online-Veranstaltungen werden bevorzugt angezeigt. Bitte prüfen Sie die Informationen genau und kontaktieren Sie ggf. den Veranstalter.
zurück zur Übersicht

Bioassays and Bioanalytics - Live Online

Datum und Zeit26.10.2021 - 27.10.2021


In Kalender übernehmen


Kosten / Gebühren1.590,00




The Live Online Training includes a general discussion of GMP, GLP and GCLP principles and how they apply to potency assays, limits tests, pharmacokinetics, pharmacodynamics and immunogenicity. Furthermore you will learn the principles of phase specific validation as they relate to potency Bioassays and limits tests. We will outline the industry guidelines on PK assays with an emphasis on the accuracy and precision expectations for biopharmaceuticals, including Incurred Sample Reanalysis. The immunogenicity section helps the participants understand important regulatory expectations by a systematic evaluation of critical portions of the EMA guidance. In addition you become acquainted with the specific challenges of transferring Bioassays between laboratories and you get a checklist to identify and overcome the hurdles in the process. Workshops on writing validation protocols provide hands-on experience to cover these pivotal documents. You will also hear case studies that add relevance to the lecture materials and provide a launch point for class discussion.


The number of biopharmaceutical products is increasing in the clinic and in the market. Their excellent targeting ability is the result of a high complexity that cannot be measured by analytical tests alone. Therefore, the development process of all biopharmaceutical products requires non-analytical tests to fully evaluate their functionality and safety. Biopharmaceutical development is a multi-disciplinary effort that involves many professionals with diverse backgrounds. This course will help team members without the appropriate technical background by clarifying the timelines, requirements and significance of Bioassays based testing. The types of methods that will be addressed are cell-based assays, immunoassays and molecular assays.

Technical Requirements

For our Live Online Training Courses and Webinars, we use Cisco WebEx, one of the leading suppliers of online meetings.

At you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in. Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.


Introduction to Bioassays and Bioanalytical Methods

* What is a potency assay?
* Product analytics versus Bioanalytics (preclinical & clinical approach)
* Why do we need bioassays?
* Characterisation of Biopharmaceuticals & Biosimilars

Regulatory Expectations and Requirements on Bioassays and Bioanalytical Methods

* Introduction and general aspects
* Bioassays and methods – expected data
* Guidance documents

GMP & G(C)(L)P Guidelines (EMA & FDA)

* Overview and Interpretation

Development of Bioactivity / Potency Assays – selecting Methods and Types of Assays

* Assay Types
* Feasibility
* Preparing the Cell Bank
* Optimization Parameters
* Replacement methods for primary assays
* Readouts

Development of Immunoassays for GCLP Bioanalytics

* Standards and controls
* Eliminating edge and hook effects
* Setting system suitability criteria

Strategies and Techniques to Improve Assays

* Improve accuracy and repeatability
* Avoid common technical errors

Statistical Analyses & Trending

Development of clinical Assays (PK/PD/ADA)

GMP Validation of Bioactivity (Potency) Assays

* Guidelines and Requirements
* Validation Parameters
* Setting Realistic Sample Specs for Validation
* Phase Specific Validation
* Validation Report


* DOE versus OFAT

Case Studies on Special Bioassays for Biopharmaceuticals and Biosimilars

* RBA mAb

Method Transfer

* How to transfer a method?
* Transfer tools during product development
* Donor and Acceptor
* Investigation, calculation and comparison of method Parameters

ReferentDr Jörg Engelbergs, Paul Ehrlich Institute, Germany
Rainer Fedra, VelaLabs, Austria
Dr Markus Fido, MFi Bio-Consulting, Austria
Dr Ulrike Herbrand, Charles River Laboratories, Germany
Dr Michael Leiss, Roche, Germany


TeilnehmerkreisZielgruppe * Manufacturing process professionals * QA/QC staff and regulatory personnel * Clinical staff, pharmacologists and toxicologists * Project managers & outsourcing personnel * Analytical chemists and biochemists

VeranstalterConcept Heidelberg GmbH
Rischerstr. 8
69123 Heidelberg

Telefon: +49 6221 84 44 0
Telefax: +49 6221 84 44 84

OrganisatorTel.: 06221 / 84 44 0

DirektlinkZur Veranstaltung